Authors:
HOLMBERG LA
DEMIRER T
ROWLEY S
BUCKNER CD
GOODMAN G
MAZIARZ R
KLARNET J
ZUCKERMAN N
HARRER G
MCCLOSKEY R
GERSH R
GOLDBERG R
NICHOLS W
JACOBS A
WEIDEN P
MONTGOMERY P
RIVKIN S
APPELBAUM FR
BENSINGER WI
Citation: La. Holmberg et al., HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) RESCUE IN PATIENTS WITH ADVANCED-STAGE III IV OVARIAN-CANCER/, Bone marrow transplantation, 22(7), 1998, pp. 651-659
Authors:
ELLEDGE RM
GREEN S
HOWES L
CLARK GM
BERARDO M
ALLRED DC
PUGH R
CIOCCA D
RAVDIN P
OSULLIVAN J
RIVKIN S
MARTINO S
OSBORNE CK
Citation: Rm. Elledge et al., BCL-2, P53, AND RESPONSE TO TAMOXIFEN IN ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(5), 1997, pp. 1916-1922
Authors:
BENSINGER WI
SCHIFFMAN KS
HOLMBERG L
APPELBAUM FR
MAZIARZ R
MONTGOMERY P
ELLIS E
RIVKIN S
WEIDEN P
LILLEBY K
ROWLEY S
PETERSDORF S
KLARNET JP
NICHOLS W
HERTLER A
MCCROSKEY R
WEAVER CH
BUCKNER CD
Citation: Wi. Bensinger et al., HIGH-DOSE BUSULFAN, MELPHALAN, THIOTEPA AND PERIPHERAL-BLOOD STEM-CELL INFUSION FOR THE TREATMENT OF METASTATIC BREAST-CANCER, Bone marrow transplantation, 19(12), 1997, pp. 1183-1189
Authors:
SCHIFFMAN KS
BENSINGER WI
APPELBAUM FR
ROWLEY S
LILLEBY K
CLIFT RA
WEAVER CH
DEMIRER T
SANDERS JE
PETERSDORF S
GOOLEY T
WEIDEN P
ZUCKERMAN N
MONTGOMERY P
MAZIARZ R
KLARNET JP
RIVKIN S
TRUEBLOOD K
STORB R
HOLMBERG L
BUCKNER CD
Citation: Ks. Schiffman et al., PHASE-II STUDY OF HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH MALIGNANT DISEASE, Bone marrow transplantation, 17(6), 1996, pp. 943-950
Authors:
MACDONALD JS
FLEMING TR
PETERSON RF
BERENBERG JL
MCCLURE S
CHAPMAN RA
EYRE HJ
SOLANKI D
CRUZ AB
GAGLIANO R
ESTES NC
TANGEN CM
RIVKIN S
Citation: Js. Macdonald et al., ADJUVANT CHEMOTHERAPY WITH 5-FU, ADRIAMYCIN, AND MITOMYCIN-C (FAM) VERSUS SURGERY ALONE FOR PATIENTS WITH LOCALLY ADVANCED GASTRIC ADENOCARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Annals of surgical oncology, 2(6), 1995, pp. 488-494
Authors:
KELLY K
CROWLEY JJ
BUNN PA
HAZUKA MB
BEASLEY K
UPCHURCH C
WEISS GR
HICKS WJ
GANDARA DR
RIVKIN S
LIVINGSTON R
Citation: K. Kelly et al., ROLE OF RECOMBINANT INTERFERON ALFA-2A MAINTENANCE IN PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG-CANCER RESPONDING TO CONCURRENT CHEMORADIATION - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 13(12), 1995, pp. 2924-2930
Authors:
BUNN PA
WEISS GR
HICKS WJ
GANDARA DR
RIVKIN S
Citation: Pa. Bunn et al., CHEMORADIOTHERAPY WITH OR WITHOUT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG-CANCER- A PROSPECTIVE PHASE-III RANDOMIZED STUDY OF THE SOUTHWEST-ONCOLOGY-GROUP (VOL 13, PG 1632, 1995), Journal of clinical oncology, 13(11), 1995, pp. 2860-2860
Authors:
FABIAN C
GIRI S
ESTES N
TANGEN CM
POPLIN E
VOGEL S
GOODWIN W
RIVKIN S
FLEMING TR
MACDONALD JS
Citation: C. Fabian et al., ADJUVANT CONTINUOUS-INFUSION 5-FU, WHOLE-ABDOMINAL RADIATION, AND TUMOR BED BOOST IN HIGH-RISK STAGE-III COLON-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP PILOT-STUDY, International journal of radiation oncology, biology, physics, 32(2), 1995, pp. 457-464
Authors:
WEAVER CH
BENSINGER WI
APPELBAUM FR
LILLEBY K
SANDMAIER B
BRUNVAND M
ROWLEY S
PETERSDORF S
RIVKIN S
GOOLEY T
WEIDEN P
ZUCKERMAN N
MONTGOMERY P
TRUEBLOOD K
KLARNET J
BUCKNER CD
Citation: Ch. Weaver et al., PHASE-I STUDY OF HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH REFRACTORY MALIGNANCIES, Bone marrow transplantation, 14(5), 1994, pp. 813-819
Citation: Lj. Lau et al., EDUCATION AND ECONOMIC-GROWTH - SOME CROSS-SECTIONAL EVIDENCE FROM BRAZIL, Journal of development economics, 41(1), 1993, pp. 45-70